ym 58483 and Asthma

ym 58483 has been researched along with Asthma in 2 studies

*Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballaron, S; BaMaung, NY; Basha, A; Bauch, J; Carter, GW; Chen, YW; Chiou, XG; Djuric, SW; Fey, T; Gauvin, D; Gubbins, E; Hsieh, GC; Liu, H; Luly, JR; Madar, DJ; Marsh, KC; Mollison, KW; Pong, M; Sciotti, RJ; Shaughnessy, TK; Sheets, MP; Smith, M; Trevillyan, JM; Tu, NP; Wagenaar, FL; Warrior, U; Wegner, CD; Wiedeman, PE; Zhou, X1
Alzina, S; De Alba, J; Esteve, C; González, J; Gual, S; Horrillo, R; Jover, I; Miralpeix, M; Sentellas, S; Tarrasón, G; Vidal, B; Vidal, L1

Other Studies

2 other study(ies) available for ym 58483 and Asthma

ArticleYear
3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulator.
    Journal of medicinal chemistry, 2000, Aug-10, Volume: 43, Issue:16

    Topics: Animals; Asthma; Cell Division; Chemokine CCL11; Chemokines, CC; Combinatorial Chemistry Techniques; Cyclosporine; Cytokines; DNA-Binding Proteins; Genes, Reporter; Haplorhini; Humans; Immunosuppressive Agents; In Vitro Techniques; Interleukin-2; Interleukin-4; Interleukin-5; Interleukin-8; Jurkat Cells; Leukocytes, Mononuclear; Luciferases; NFATC Transcription Factors; Nuclear Proteins; Protein Synthesis Inhibitors; Pyrazoles; Rats; Transcription Factors

2000
Discovery of 7-azaindole derivatives as potent Orai inhibitors showing efficacy in a preclinical model of asthma.
    Bioorganic & medicinal chemistry letters, 2015, Mar-15, Volume: 25, Issue:6

    Topics: Animals; Asthma; Aza Compounds; Calcium Channel Blockers; Calcium Channels; Disease Models, Animal; Drug Evaluation, Preclinical; Half-Life; Humans; Hypersensitivity; Indoles; Interleukin-2; Jurkat Cells; Microsomes; Models, Biological; Ovalbumin; Protein Binding; Pyridines; Pyrroles; Rats; Structure-Activity Relationship

2015